EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Pancreatic neuroendocrine tumors in patients with tuberous sclerosis: a multicenter study and systematic review

Kalyan Mansukhbhai Shekhda, John Howat, Yujia Gao, Anat Bel-Ange, Simona Grozinsky-Glasberg, Gregory Kaltsas, Kai Man Alexander Ho, Aimee R Hayes, Dalvinder Mandair, Christos Toumpanakis, Efthimia Karra, Richard A Dixon, Deirdre Donnelly, Elizabeth A Jones, Colin H Jones, Finbar O’Callaghan, Asheesh Sharma, Kirsten Slaney, Aviva Frydman, Rajaventhan Srirajaskanthan, Nabil Kibrya, Martyn Caplin, Frances Elmslie, Ashley Grossman

Journal of the Endocrine Society · 2026-08-01 · 10 (9)

DOI: 10.1210/jendso/bvag178 ↗
AbstractBibliografische Angaben

Abstract

Abstract Introduction Pancreatic neuroendocrine tumors (pNETs) are a recognized feature of tuberous sclerosis complex (TSC). The current evidence suggests that pNETs occurring in TSC may exhibit a different clinical course from sporadic cases, but their natural history remains poorly characterized. Objective This study aimed to characterize the demographics, clinical presentation, management, and long-term outcomes of TSC-associated-pNETs and to propose possible guidelines for surveillance and management. Materials and Methods We conducted a multicenter retrospective review of TSC-pNET patients from 6 UK TSC specialist clinics and from 3 NET referral centers, from 2008 to 2024. Data on demographics, tumor characteristics, management, and outcomes, were collected. A systematic review of the literature from 2009 to 2026 on TSC-pNETs was also performed. Results We identified a total of 26 consecutive cases with the TSC-pNET-association in our cohort: 21 cases of pNETs from TSC specialist clinics (1.1% of the population), and 5 cases of TSC-pNETs from the NET referral centers (0.25% of the population). An additional 80 cases were identified from the published literature. We observed a wide spectrum of clinical phenotypes, with the majority being nonfunctioning pNETs (n = 24; 92%), whereas 2 patients were diagnosed with glucagonomas. Surgical intervention was the mainstay initial treatment, the indication being either functional pNETs, or large or symptomatic nonfunctioning pNETs. Conclusion TSC-pNETs are rare and mostly nonfunctioning tumors with variable clinical behavior. Due to their uncertain malignant potential, we suggest that baseline pancreatic imaging should be incorporated into TSC surveillance, and we emphasize the need for heightened pNET surveillance and updated management recommendations.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →